UC's $15 million to fight opioid deaths makes local headlines
A recap of media coverage following the HHS' HEALing Communities announcement
On Thursday, April 18, Health and Human Services (HHS) Secretary Alex Azar announced the launch of the HEALing Communities Study to help reverse our nation’s opioid crisis. Four states – Ohio, Kentucky, Massachusetts and New York, will receive over $350 million to support a multi-year study with the goal to cut opioid overdose deaths by 40% in three years. The announcement made news across Ohio and the region.
Funded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), University of Cincinnati and Ohio State University will co-lead a $65.9 million effort across Ohio that will also partner with Recovery Ohio and Case Western Reserve University as well as additional universities and community organizations in 19 counties across Ohio. UC will be awarded $15.1 million over four years. Read the full story here.
HEALing Communities Award in the news:
WLW-700 AM(interview at 69:25 minute mark.)
Featured image at top: Jennifer Brown, PhD, presents at the UC / UC Health Opioid Symposium. Photo by Colleen Kelley/AHC Communication Services.
Related Stories
Recent advances may speed time to endometriosis diagnosis
March 16, 2026
The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.